Keratoderma, Palmoplantar: Clinical Trials

1 trial for Keratoderma, Palmoplantar, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 not yet recruiting. 1 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 11Not yet recruiting 1
Phase 21Not yet recruiting 1

Follow Keratoderma, Palmoplantar: new trials by email Literature Review of Keratoderma, Palmoplantar trials Research Report on Keratoderma, Palmoplantar

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Epidermal Growth Factor Receptor Inhibition for Keratinopathies
Erlotinib - Epidermolytic Ichthyosis, Palmoplantar Keratoderma
Phase 1 / Phase 2Not yet recruitingNorthwestern University442027-07-012026-08-03

Narrower conditions

Hyperkeratosis, Epidermolytic (1)  ·  Pachyonychia Congenita (1)

Broader conditions

Abnormalities, Multiple (1)  ·  Congenital Abnormalities (1)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1)  ·  Ectodermal Dysplasia (1)  ·  Genetic Diseases, Inborn (1)  ·  Ichthyosiform Erythroderma, Congenital (1)  ·  Ichthyosis (1)  ·  Infant, Newborn, Diseases (1)  ·  Keratosis (1)  ·  Nail Diseases (1)  ·  Skin Abnormalities (1)  ·  Skin Diseases (1)  ·  Skin Diseases, Genetic (1)  ·  Skin and Connective Tissue Diseases (1)

Interventions

Erlotinib Hydrochloride (1)

Sponsors

Northwestern University (1)

Countries

United States (1)

Top investigators

Amy Paller (1)